Steven H. Collis
Chairman, President & CEO at Cencora Inc. · b. 1961
Sits on 3 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 3 boards, counting each seat separately. Longest: Cencora Inc., 3 years.
Chief executive roles
Outstanding · grade A
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 50% of the scoring weight is on file.
- Dividends 15%
- 89
- Revenue growth 20%
- 79
- Earnings growth 15%
- 76
dividend grew 13.7% a year
9.9% a year in revenue
8.9% a year in earnings per share
50% of the scoring weight is on file. Figures cover September 2010 – September 2025.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Bausch + Lomb Corporation May 20, 202698.7%
-
Cencora Inc. March 6, 202597.8%
-
Cencora Inc. March 12, 202496.0%
-
Cencora Inc. March 9, 202394.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 26, 2026 | Bausch + Lomb Corporation | Grant or award | +15,842 | $15.78 | $249,987 |
| May 13, 2026 | Elevance Health Inc. | Grant or award | +563 | — | — |
| Apr 30, 2026 | Bausch + Lomb Corporation | Grant or award | +1,415 | $15.90 | $22,499 |
| Mar 5, 2026 | Elevance Health Inc. | Open-market purchase | +3,000 | $289.84 | $869,520 |
| Feb 23, 2026 | Bausch + Lomb Corporation | Open-market purchase | +15,000 | $17.81 | $267,150 |
| Feb 23, 2026 | Bausch + Lomb Corporation | Grant or award | +4,491 | — | — |
| Feb 19, 2026 | Bausch + Lomb Corporation | Grant or award | +5,255 | — | — |
| Sep 16, 2025 | Cencora Inc. | Option exercise | +29,350 | $86.09 | $2,526,742 |
| Sep 16, 2025 | Cencora Inc. | Open-market sale | −31,350 | $289.86 | $9,087,111 |
| Aug 19, 2025 | Cencora Inc. | Option exercise | +12,579 | $86.09 | $1,082,926 |
| Aug 19, 2025 | Cencora Inc. | Open-market sale | −14,579 | $289.98 | $4,227,618 |
| Aug 1, 2025 | Elevance Health Inc. | Grant or award | +639 | — | — |
| Jul 22, 2025 | Cencora Inc. | Option exercise | +12,578 | $86.09 | $1,082,840 |
| Jul 22, 2025 | Cencora Inc. | Open-market sale | −14,578 | $292.67 | $4,266,543 |
| Jun 24, 2025 | Cencora Inc. | Option exercise | +12,579 | $86.09 | $1,082,926 |
Questions about Steven H. Collis
What boards is Steven H. Collis on?
Steven H. Collis sits on the boards of Bausch + Lomb Corporation, Cencora Inc. and Elevance Health Inc.
What company is Steven H. Collis the CEO of?
Steven H. Collis has been Chairman, President & CEO of Cencora Inc. since July 2011.
How long has Steven H. Collis served on boards?
Our records show at least 6 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.